Log in
NASDAQ:FLGT

Fulgent Genetics Earnings Date, Estimates & History

$40.63
+4.12 (+11.28 %)
(As of 11/27/2020 12:00 AM ET)
Add
Compare
Today's Range
$37.14
Now: $40.63
$41.70
50-Day Range
$31.01
MA: $38.40
$46.05
52-Week Range
$6.70
Now: $40.63
$52.47
Volume1.49 million shs
Average Volume669,865 shs
Market Capitalization$986.25 million
P/E Ratio338.61
Dividend YieldN/A
Beta1.75

Earnings

Fulgent Genetics (NASDAQ:FLGT) Earnings Information

Fulgent Genetics last announced its quarterly earnings results on November 9th, 2020. The reported $2.08 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.39 by $1.69. Fulgent Genetics has generated $0.02 earnings per share over the last year and currently has a price-to-earnings ratio of 338.6. Fulgent Genetics has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 9th, 2021 based off prior year's report dates.

Fulgent Genetics Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

Fulgent Genetics (NASDAQ:FLGT) Earnings Estimates

2020 EPS Consensus Estimate: $2.12
2021 EPS Consensus Estimate: $5.41
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20202($0.06)$0.01($0.03)
Q2 20201$0.01$0.01$0.01
Q3 20201$0.05$0.05$0.05
Q4 20201$2.08$2.08$2.08
Q1 20211$1.72$1.72$1.72
Q2 20211$1.54$1.54$1.54
Q3 20211$1.17$1.17$1.17
Q4 20211$0.98$0.98$0.98

Fulgent Genetics (NASDAQ FLGT) Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSGAAP EPSRevenue EstimateActual RevenueConference CallDetails
3/9/2021
(Estimated)
       
11/9/2020Q3$0.39$2.08$1.92Transcript
8/4/20206/30/2020$0.01$0.17$0.20$14.52 million$17.27 millionTranscript
5/4/20203/31/2020$0.02($0.03)($0.07)$7.69 million$7.75 millionTranscript
3/10/202012/31/2019$0.04$0.04$0.01$9.02 million$8.39 millionTranscript
11/4/2019Q3 2019$0.01$0.09$0.10$8.48 million$10.35 millionN/A
8/5/2019Q2 2019($0.04)$0.02$0.02$6.42 million$8.42 millionTranscript
5/7/20193/31/2019($0.06)($0.09)($0.08)$5.46 million$5.37 millionTranscript
2/28/2019Q4 2018($0.01)($0.03)($0.01)$5.90 million$5.68 millionN/A
11/6/2018Q3 2018($0.03)($0.03)($0.03)$5.63 millionN/A
8/6/2018Q2 2018($0.03)($0.01)($0.02)$4.97 million$5.40 millionN/A
5/7/2018Q1 2018($0.04)($0.06)($0.05)$4.65 millionN/A
2/28/2018Q4 2017($0.03)($0.09)($0.08)$5.26 million$4.28 millionN/A
11/6/2017Q3 2017($0.05)($0.04)$5.52 million$4.50 millionN/A
8/7/2017Q2 2017$0.0160$0.02$5.03 million$4.64 millionListen
5/8/2017Q1 2017$0.03$0.02$0.03$5.85 million$5.31 millionListen
2/27/2017Q416$0.04$0.05$0.05$5.99 million$5.85 millionListen
11/14/2016Q3 2016$0.08($0.44)($0.44)$5.16 million$5.01 millionN/A
(Earnings results data provided by Zacks Investment Research)
This page was last updated on 11/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.